Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 4 of 37 for:    "congenital diaphragmatic hernia"

Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia

This study is currently recruiting participants. (see Contacts and Locations)
Verified December 2015 by Massachusetts General Hospital
Boston Children’s Hospital
Information provided by (Responsible Party):
Patricia Donahoe, MD, Massachusetts General Hospital Identifier:
First received: March 31, 2010
Last updated: December 16, 2015
Last verified: December 2015
Congenital diaphragmatic hernia (CDH) occurs when the diaphragm, the muscle that separates the chest cavity from the abdominal cavity, does not form properly. When an opening is present in the diaphragm, organs that are normally found in the abdomen can move up into the chest cavity. The primary objective of this study is to generate information about the hereditary basis of congenital diaphragmatic hernia and abnormal lung development. Our long-term goal is to identify ways to treat babies in utero with effective but safe drugs to speed up lung development before birth.

Congenital Diaphragmatic Hernia

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia

Resource links provided by NLM:

Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • identify genes associated with CDH [ Time Frame: 5 years ]

Biospecimen Retention:   Samples With DNA
whole blood, tissue, saliva, urine

Estimated Enrollment: 1000
Study Start Date: July 2002
Estimated Study Completion Date: July 2017
Estimated Primary Completion Date: July 2017 (Final data collection date for primary outcome measure)
Congenital Diaphragmatic Hernia (CDH)
Individuals affected with congenital diaphragmatic hernia (CDH)
Healthy family members of individuals affected with congenital diaphragmatic hernia (CDH)

Detailed Description:

This study uses a combination of clinical, molecular biological, and developmental strategies to better understand the genetic basis of congenital diaphragmatic hernia. Ongoing projects at Massachusetts General Hospital include identification of novel genes affecting diaphragm and lung development in a) mouse models using laser capture, microdissection, expression arrays, and statistical and bioinformatics analysis and b) human kindreds with multiple affected family members using linkage analysis and exome sequencing.

Research projects based at Children's Hospital Boston include a) continued recruitment of a population of patients with congenital diaphragmatic hernia who are carefully phenotyped for entry into an extensive database, b) collection of biological samples belonging to the phenotyped cohort of patients, c) next-generation sequencing on candidate genes and d) molecular cytogenetic studies such as comparative genomic hybridization and subtelomeric fluorescence in situ hybridization.

Over 500 patients with congenital diaphragmatic hernia and their families have been recruited to date and efforts are ongoing to double this number. The investigators hope that the information gained through identifying the genes that contribute to congenital diaphragmatic hernia will provide the foundation for future efforts to develop effective interventions for the treatment of this disease.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

Children/infants with a congenital diaphragmatic hernia

Women who are currently pregnant with a fetus diagnosed with congenital diaphragmatic hernia

Individuals with a family history of congenital diaphragmatic hernia


Inclusion Criteria:

All individuals affected with a congenital diaphragmatic hernia (CDH), or with a family history of CDH

Exclusion Criteria:

Individuals with no personal or family history of a CDH

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01098929

Contact: Jessica Kim, BS 617-355-2555

United States, Massachusetts
Children's Hospital Boston Recruiting
Boston, Massachusetts, United States, 02215
Contact: Jessica Kim, BS    617-355-2555   
Principal Investigator: Jay Wilson, MD         
Sponsors and Collaborators
Massachusetts General Hospital
Boston Children’s Hospital
Principal Investigator: Patricia Donahoe, MD Massachusetts General Hospital
Principal Investigator: Jay Wilson, MD Boston Children’s Hospital
  More Information

Responsible Party: Patricia Donahoe, MD, Principal Investigator and Program Director, Pediatric Surgical Research Laboratories, Massachusetts General Hospital Identifier: NCT01098929     History of Changes
Other Study ID Numbers: 05-07-105R
Study First Received: March 31, 2010
Last Updated: December 16, 2015

Keywords provided by Massachusetts General Hospital:
chromosome microarray

Additional relevant MeSH terms:
Hernia, Diaphragmatic
Hernias, Diaphragmatic, Congenital
Pathological Conditions, Anatomical
Congenital Abnormalities processed this record on May 22, 2017